欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NO/H/0243/001
药品名称Ceftazidime MIP 1 g
活性成分
    • ceftazidime pentahydrate 1.0 g
剂型Powder for solution for infusion/injection
上市许可持有人MIP Pharma GmbH Kirkeler Strasse 41 D-66440 Blieskastel Germany
参考成员国 - 产品名称Norway (NO)
Ceftazidim MIP
互认成员国 - 产品名称
    • Germany (DE)
      Ceftazidim MIP 1 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung
    • Denmark (DK)
    • Netherlands (NL)
      Ceftazidim MIP 1 g, poeder voor oplossing voor injectie of infusie
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      Ceftazidim-MIP 1 g Pulver zur Herstellung einer Injektions-/Infusionslösung
    • France (FR)
    • Spain (ES)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Ceftazidime MIP 1 g pulveris injekciju/infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Ceftazidime MIP 1 g milteliai injekciniam ar infuziniam tirpalui
    • Estonia (EE)
      CEFTAZIDIME MIP 1G
    • Hungary (HU)
      CEFTAZIDIM MIP 1 g por oldatos injekcióhoz vagy infúzióhoz
    • Bulgaria (BG)
      Ceftazidime-MIP
    • Czechia (CZ)
      Ceftazidim MIP 1 g
    • Romania (RO)
      Ceftazidima MIP 1 g pulbere pentru soluţie injectabilă/perfuzabilă
    • Slovakia (SK)
      Ceftazidime-MIP 1 g
许可日期2015/02/12
最近更新日期2021/06/02
药物ATC编码
    • J01DD02 ceftazidime
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase